• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    More On ANP.AX

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Antisense Therapeutics Ltd. (ANP.AX)

    -ASX
    0.04 Down 0.00(8.33%) Feb 11, 11:29PM EST
    Prev Close:0.05
    Open:0.05
    Bid:0.04
    Ask:0.05
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:0.04 - 0.05
    52wk Range:0.04 - 0.17
    Volume:491,297
    Avg Vol (3m):122,283
    Market Cap:7.77M
    P/E (ttm):11.00
    EPS (ttm):0.00
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in AUD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1.83
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Antisense Therapeutics Limited engages in the research, development, and commercialization of novel antisense pharmaceuticals in Australia. The company’s product pipeline comprises ATL1102, an antisense inhibitor targeting VLA-4 for the treat... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback